Results 131 to 140 of about 146,093 (222)

Cardioprotective Effects Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin 1-7 in Experimental Heart Failure in Angiotensin-Converting Enzyme 2–Null Mice

HYPERTENSION, 2012
Vaibhav B. Patel, Sreedhar Bodiga, D. Fan, Subhash K. Das, Zuocheng Wang, Wang Wang, R. Basu, J. Zhong, Z. Kassiri, G. Oudit   +9 more
semanticscholar   +1 more source

Repurposing Renin-Angiotensin System Drugs for the Treatment of Audiovestibular Disorders. [PDF]

J Clin Med
Podhajsky G, Marla KS, Marticoff AP, Nguyen K, Kempton T, Salehpour S, Duffy C, Bennion DM.   +7 more
europepmc   +1 more source

Effects of angiotensin II type 1 receptor blocker on bones in mice with type 1 diabetes induced by streptozotocin [PDF]

, 2013
Yan Zhang, Teng-Yue Diao, Sa-Sa Gu, Shu-Yan Wu, Yoseph Asmelash Gebru, Xi Chen, Jingyu Wang, Shu Ran, Man‐Sau Wong   +8 more
openalex   +1 more source

Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024). [PDF]

Biomolecules
Chatzipieris FP, Petsas E, Lambrinidis G, Matsoukas JM, Mavromoustakos T.   +4 more
europepmc   +1 more source

Efficacy and Safety of Angiotensin II Type 1 Receptor Blocker/Calcium Channel Blocker Combination Therapy for Hypertension: Focus on a Single-Pill Fixed-Dose Combination of Valsartan and Amlodipine [PDF]

, 2012
Shinpei Miura, Keijiro Saku
openalex   +1 more source

Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state.

Molecular Endocrinology, 2008
S. Miura, Y. Kiya, T. Kanazawa, S. Imaizumi, M. Fujino, Yoshino Matsuo, S. Karnik, K. Saku   +7 more
semanticscholar   +1 more source

High-Dimensional Propensity Scores for Mitigating Confounding: Implementation Using Primary and Secondary Care Data in Hong Kong. [PDF]

Pharmacoepidemiol Drug Saf
Cheung ECL, Fan M, Chui CSL, Wong AYS, Tazare J.   +4 more
europepmc   +1 more source

Losartan Metabolite EXP3179 Activates Akt and Endothelial Nitric Oxide Synthase via Vascular Endothelial Growth Factor Receptor-2 in Endothelial Cells: Angiotensin II Type 1 Receptor–Independent Effects of EXP3179

Circulation, 2005
Tetsu Watanabe, J. Suzuki, H. Yamawaki, V. Sharma, S. Sheu, B. Berk   +5 more
semanticscholar   +1 more source

Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry. [PDF]

Eur J Heart Fail
Inciardi RM, Volterrani M, Savarese G, Vaduganathan M, Oriecuia C, Lombardi CM, Gussago C, Agostoni P, Ameri P, Armentaro G, Arzilli C, Aspromonte N, Attanasio A, Badagliacca R, Barbieri L, Bocchino PP, Bursi F, Cameli M, Canonero M, Campodonico JS, Capovilla T, Carluccio E, Carugo S, Castiglione V, Catapano D, Cipriani M, Correale M, D'Amario D, De Caterina R, De Ferrari GM, D'Elia E, Di Odoardo L, Emdin M, Falco L, Ferrante G, Fornaro A, Fornaro P, Guastamiglio G, Guazzi M, Iacoviello M, Imazio M, Incaminato E, La Rovere MT, Leonardi S, Maccallini M, Mandoli GE, Masarone D, Masetti M, Mazzoni A, Mazzotta M, Merlo M, Moschini L, Novarese F, Palazzuoli A, Pastore MC, Patti G, Pedretti RFE, Pidello S, Piepoli MF, Pinto G, Potena L, Raineri C, Rubbo FM, Sabatino M, Salzano A, Sciacqua A, Senni M, Severino P, Sinagra G, Sposato B, Taddei S, Valleggi A, Vignati C, Vizza D, Specchia C, Rosano G, Metra M, OPTIPHARM‐HF investigators.   +77 more
europepmc   +1 more source

Telmisartan, an angiotensin II type 1 receptor blocker, reduces IOP and prevents axon loss in mice with experimental glaucoma

, 2019
Ralph J. Hazlewood, John Kuchtey, Rachel W. Kuchtey   +2 more
openalex   +1 more source